Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 24 Nov 2016
Price : $35 *
At a glance
- Drugs Hepatitis A-hepatitis B vaccine (Primary)
- Indications Hepatitis A; Hepatitis B
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 17 Nov 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 16 Sep 2014 Planned initiation date changed from 1 Jul 2014 to 1 May 2015 as reported by ClinicalTrials.gov record.
- 30 May 2014 Planned initiation date changed from 1 May 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov..